1. Home
  2. RVPHW vs LANDM Comparison

RVPHW vs LANDM Comparison

Compare RVPHW & LANDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPHW
  • LANDM
  • Stock Information
  • Founded
  • RVPHW N/A
  • LANDM N/A
  • Country
  • RVPHW United States
  • LANDM United States
  • Employees
  • RVPHW 15
  • LANDM N/A
  • Industry
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • LANDM Real Estate Investment Trusts
  • Sector
  • RVPHW Health Care
  • LANDM Real Estate
  • Exchange
  • RVPHW Nasdaq
  • LANDM Nasdaq
  • Market Cap
  • RVPHW N/A
  • LANDM N/A
  • IPO Year
  • RVPHW 2018
  • LANDM N/A
  • Fundamental
  • Price
  • RVPHW $0.12
  • LANDM $24.52
  • Analyst Decision
  • RVPHW
  • LANDM
  • Analyst Count
  • RVPHW 0
  • LANDM 0
  • Target Price
  • RVPHW N/A
  • LANDM N/A
  • AVG Volume (30 Days)
  • RVPHW N/A
  • LANDM N/A
  • Earning Date
  • RVPHW N/A
  • LANDM N/A
  • Dividend Yield
  • RVPHW N/A
  • LANDM N/A
  • EPS Growth
  • RVPHW N/A
  • LANDM N/A
  • EPS
  • RVPHW N/A
  • LANDM N/A
  • Revenue
  • RVPHW N/A
  • LANDM N/A
  • Revenue This Year
  • RVPHW N/A
  • LANDM N/A
  • Revenue Next Year
  • RVPHW N/A
  • LANDM N/A
  • P/E Ratio
  • RVPHW N/A
  • LANDM N/A
  • Revenue Growth
  • RVPHW N/A
  • LANDM N/A
  • 52 Week Low
  • RVPHW N/A
  • LANDM N/A
  • 52 Week High
  • RVPHW N/A
  • LANDM N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVPHW N/A
  • LANDM 52.57
  • Support Level
  • RVPHW N/A
  • LANDM $24.43
  • Resistance Level
  • RVPHW N/A
  • LANDM $24.67
  • Average True Range (ATR)
  • RVPHW 0.00
  • LANDM 0.12
  • MACD
  • RVPHW 0.00
  • LANDM -0.00
  • Stochastic Oscillator
  • RVPHW 0.00
  • LANDM 51.61

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About LANDM Gladstone Land Corporation 5.00% Series D Cumulative Term Preferred Stock

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment. It is focused on the ownership of high-quality farms and farm-related properties that are leased on a triple-net basis to tenants with a strong operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also own farms that grow certain commodity crops (e.g., corn and beans).

Share on Social Networks: